Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.366
https://www.valueinhealthjournal.com/article/S1098-3015(16)31733-8/fulltext
Title :
Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31733-8&doi=10.1016/j.jval.2016.09.366
First page :
A409
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
339